← Browse by Condition
Medical Condition

post traumatic stress disorder ptsd

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for post traumatic stress disorder ptsd sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — post traumatic stress disorder ptsd Clinical Trials

How many clinical trials are currently recruiting for post traumatic stress disorder ptsd?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for post traumatic stress disorder ptsd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for post traumatic stress disorder ptsd?
post traumatic stress disorder ptsd research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a post traumatic stress disorder ptsd clinical trial?
Eligibility criteria for post traumatic stress disorder ptsd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance 1 trial
The University of Texas Health Science Center at San Antonio 1 trial
The Center for Mind-Body Medicine 1 trial
Tel Aviv University 1 trial
Montefiore Medical Center 1 trial

Recruiting Clinical Trials

NCT06335407 Phase 1
Recruiting
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
Enrollment
10 pts
Location
United States
Sponsor
Pharmacotherapies for Alcohol ...
View Trial →
NCT07401225
Recruiting
TMS for PTSD in Youth
Enrollment
20 pts
Location
United States
Sponsor
The University of Texas Health...
View Trial →
NCT07302984
Recruiting
Mind-body Skills Groups for War-Related Trauma in Adolescents in Gaza
Enrollment
120 pts
Location
Palestinian Territor...
Sponsor
The Center for Mind-Body Medic...
View Trial →
NCT06968312
Recruiting
Hexadecanal as an Addon to Cognitive Processing Therapy for PTSD
Enrollment
40 pts
Location
Israel
Sponsor
Tel Aviv University
View Trial →
NCT05929911
Recruiting
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
Enrollment
20 pts
Location
United States
Sponsor
Montefiore Medical Center
View Trial →

Related Conditions

alcohol use disorder aud (1) hiv (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology